ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,327 | -38.9% | 27,976 | +8.4% | 0.00% | – |
| Q2 2023 | $62,719 | -53.2% | 25,810 | +10.6% | 0.00% | – |
| Q1 2023 | $134,000 | +84176.7% | 23,328 | +31.0% | 0.00% | – |
| Q4 2022 | $159 | -99.9% | 17,812 | -2.9% | 0.00% | – |
| Q3 2022 | $261,000 | +5.7% | 18,350 | +8.3% | 0.00% | – |
| Q2 2022 | $247,000 | -26.3% | 16,943 | +1.1% | 0.00% | – |
| Q1 2022 | $335,000 | +35.6% | 16,766 | +18.1% | 0.00% | – |
| Q4 2021 | $247,000 | +165.6% | 14,202 | +20.8% | 0.00% | – |
| Q3 2021 | $93,000 | -5.1% | 11,752 | +23.5% | 0.00% | – |
| Q2 2021 | $98,000 | +1860.0% | 9,516 | +2397.6% | 0.00% | – |
| Q4 2020 | $5,000 | – | 381 | +12600.0% | 0.00% | – |
| Q3 2020 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |